In Vitro Diagnostics Market Trends to 2023 “Driven by Clinical Chemistry and Molecular Diagnostics”

The major factors driving the growth of In Vitro Diagnostics market in the North American region include accessibility to advanced technologies, increasing demand for laboratory automation, expansion of molecular diagnostics for genetic disorders and cancer screening, and presence of major leading companies in the US.

In Vitro Diagnostics Market Research Sample Papers is now available at https://www.reportsnreports.com/contacts/requestsample.aspx?name=266706 .

The in vitro diagnostics market is projected to reach USD 87.93 billion by 2023 from USD 68.12 billion in 2018, at a CAGR of 5.2%. Growth in this market is primarily driven by the increasing burden of chronic diseases (majorly due to the rising geriatric population), rising prevalence of infectious diseases, rising demand for early disease diagnosis using specialized tests, growing awareness of personalized medicine, and increasing adoption of fully-automated instruments and automation in laboratories.

List of companies profiled in the report
• Roche Diagnostics (Switzerland)
• Siemens Healthineers (Germany)
• Danaher Corporation (US)
• Abbott Laboratories (US)
• Thermo Fisher Scientific (US)
• Johnson & Johnson (US)
• Becton, Dickinson and Company (US)
• Bio-Rad Laboratories (US)
• Sysmex Corporation (Japan)
• bioMérieux (France)
• DiaSorin (Italy)
• Ortho Clinical Diagnostics (US)
• QIAGEN (Germany)
• Agilent Technologies (US)

Get the Overview of In Vitro Diagnostics Market with Company Profiles Now at https://www.reportsnreports.com/contacts/inquirybeforebuy.aspx?name=266706 .

The study estimates the in vitro diagnostics market size for 2018 and projects its demand till 2023. In the primary research process, various sources from both demand side and supply side were interviewed to obtain qualitative and quantitative information for the report. Primary sources from the supply side include various industry CEOs, vice presidents, marketing directors, technology and innovation directors, and related key executives from the various players in the market

Target Audience for this Report:
• IVD Product Manufacturers
• Group Purchase Organizations (GPOs)
• OEM Manufacturers
• Pathologists and Pathology Laboratories
• Distributors of IVD Products
• Hospitals and Clinics
• Healthcare Institutions
• Research Institutes
• Market Research and Consulting Firms
• Venture Capitalists and Investors

Get Discount on “In Vitro Diagnostics/IVD Market by Product (Instruments, Reagents), Technology (Immunoassay, Clinical Chemistry, Molecular Diagnostics, Hematology, Urinalysis), Application (Diabetes, Oncology, Cardiology, Nephrology) - Forecast to 2023” report @ https://www.reportsnreports.com/contacts/discount.aspx?name=266706 .

Report studies in vitro diagnostics market based on product & service, technology, application, end user, and region. Report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth. It analyzes opportunities and challenges in market for stakeholders and provides in-depth competitive analysis of key players in market along with their company profiles, recent developments, and key market strategies.

Key Benefits of Buying the Report:
• The report will help the market leaders/new entrants in this market by providing them with the closest approximations of revenues for the overall in vitro diagnostics market and its segments.
• This report will help stakeholders to understand the competitive landscape better and gain insights to position their businesses and help companies make suitable go-to-market strategies.
• The report also helps stakeholders understand the pulse of the market and provide them with information regarding key market drivers and opportunities.

Contact:
sales@reportsandreports.com / Call +1 888 391 5441

ReportsnReports provides you the further information and more details with intelligence needs for your business. Access to in-depth market trends helps companies to assess the market effectiveness.

Tower B5, Office 101,
Magarpatta City SEZ,
Pune-411013, India

This release was published on openPR.